Inventor · disambiguated record
Michael Eissenstat
Also filed as: EISSENSTAT MICHAEL · EISSENSTAT MICHAEL A
26 granted patents·6 pending applications·103 citations·filing 2000–2016
95Inventor score
Files withSEQUOIA PHARMACEUTICALS INC13EISSENSTAT MICHAEL8SEQUOIA PHARMACEUTICALS4US HEALTH3TIBOTEC PHARM LTD2
Top patents by PatentIndex Score
32 records- 0191US9403789B2Benzofuran-containing amino acid inhibitors of cytochrome P450EISSENSTAT MICHAEL·Filed 2009·Granted Aug 2, 2016·19 cites·18 claims
- 0287US7981929B2Benzofuran derived HIV protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2008·Granted Jul 19, 2011·5 cites·35 claims
- 0384US6649651B1Hexahydrofuro[2,3-B]furan-3-yl-n{3[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitorTIBOTEC PHARM LTD·Filed 2000·Granted Nov 18, 2003·18 cites·17 claims
- 0482US8048871B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2007·Granted Nov 1, 2011·5 cites·25 claims
- 0580US7109230B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2003·Granted Sep 19, 2006·9 cites·26 claims
- 0679US8389571B2Benzofuran derived HIV protease inhibitorsEISSENSTAT MICHAEL·Filed 2011·Granted Mar 5, 2013·2 cites·20 claims
- 0779US7285566B2Resistance-repellent retroviral protease inhibitorsERICKSON JOHN W·Filed 2003·Granted Oct 23, 2007·8 cites·27 claims
- 0878US8906647B2Diamide inhibitors of cytochrome P450EISSENSTAT MICHAEL·Filed 2009·Granted Dec 9, 2014·3 cites·18 claims
- 0978US6613764B1Aspartic protease inhibitorsUS HEALTH·Filed 2000·Granted Sep 2, 2003·10 cites·31 claims
- 1077US8673970B2HIV protease inhibitor and cytochrome p450 inhibitor combinationsEISSENSTAT MICHAEL·Filed 2009·Granted Mar 18, 2014·3 cites·18 claims
- 1176US7507763B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS·Filed 2006·Granted Mar 24, 2009·3 cites·13 claims
- 1276US7378441B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2005·Granted May 27, 2008·4 cites·26 claims
- 1374US7157495B2Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitorUS HEALTH·Filed 2003·Granted Jan 2, 2007·6 cites·51 claims
- 1472US8791157B25-substituted benzofurans as inhibitors of cytochrome P450 2D6SEQUOIA PHARMACEUTICALS INC·Filed 2013·Granted Jul 29, 2014·2 cites·13 claims
- 1572US7807845B2Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2005·Granted Oct 5, 2010·3 cites·17 claims
- 1670US9540354B2Diamide inhibitors of cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2014·Granted Jan 10, 2017·1 cites·22 claims
- 1769US8765667B2HCV protease inhibitorsEISSENSTAT MICHAEL·Filed 2009·Granted Jul 1, 2014·2 cites·26 claims
- 1866US2006258737A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1963US2010056596A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 2063US2010009935A1Resistance-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS·Filed 2009·Application pending·0 cites
- 2161US8569364B25-substituted benzofurans as inhibitors of cytochrome P450 2D6EISSENSTAT MICHAEL·Filed 2008·Granted Oct 29, 2013·0 cites·5 claims
- 2261US2006293286A1Resistant-repellent retroviral protease inhibitorsSEQUOIA PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2360US9604952B2Compositions and methods for inhibiting cytochrome P450 2D6SEQUOIA PHARMACEUTICALS INC·Filed 2014·Granted Mar 28, 2017·0 cites·10 claims
- 2458US9233952B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2013·Granted Jan 12, 2016·0 cites·21 claims
- 2555US8952056B2Methods for inhibiting drug degradationEISSENSTAT MICHAEL·Filed 2009·Granted Feb 10, 2015·0 cites·15 claims
- 2654US8481520B2Compositions and methods for inhibiting cytochrome P450EISSENSTAT MICHAEL·Filed 2011·Granted Jul 9, 2013·0 cites·22 claims
- 2752US9849107B2Compositions and methods for inhibiting cytochrome P450SEQUOIA PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·0 cites·20 claims
- 2846US2007207952A1Long Acting Biologically Active ConjugatesSEQUOIA PHARMACEUTICALS·Filed 2004·Application pending·0 cites
- 2944US7132420B2Aspartic protease inhibitorsUS HEALTH·Filed 2003·Granted Nov 7, 2006·0 cites·26 claims
- 3040US2015284352A1Methods for inhibiting drug degradationSEQUOIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3136US7429677B2Small molecule entry inhibitorsTIBOTEC PHARM LTD·Filed 2003·Granted Sep 30, 2008·0 cites·4 claims
- 3229US8703700B2Bimacrocylic HCV NS3 protease inhibitorsMAJER PAVEL·Filed 2010·Granted Apr 22, 2014·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Michael Eissenstat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →